Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Canepa

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
International Journal of Cardiology|November 7, 2025
Impact of cardiac magnetic resonance on the clinical management of patients with Fabry disease: Data from the CMR Italian research and CLinical nEtwork for Fabry disease (CIRCLE-FD)Antonia Camporeale, Giada De Angeli, Gianluigi Guida, et al.
Circulation. Heart Failure|February 24, 2026
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac AmyloidosisMattia Zampieri, Giulia Biagioni, Annamaria Del Franco, et al.
ESC Heart Failure|May 14, 2021
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide surveyGiacomo Tini, Francesco Cappelli, Elena Biagini, et al.
ESC Heart Failure|November 30, 2022
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic RegistryGiulia Elena Mandoli, Maria Concetta Pastore, Alberto Giannoni, et al.
Circulation|February 8, 2024
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Marianna Fontana, Marco Canepa, et al.
Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)]Aldostefano Porcari, Cristina Chimenti, Marco Merlo, et al.
Journal of the American College of Cardiology|June 12, 2024
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Francesco Cappelli, Christian Nitsche, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Tissue characterization in cardiac amyloidosis: a joint consensus document by the gruppo di studio di cardiopatologia (SIAPEC) and the SIC/ANMCO Italian cardiac amyloidosis network (RIAC)Giuseppe Vergaro, Carla Giordano, Angela Pucci, et al.
European Heart Journal Open|August 3, 2022
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian registerMaria Concetta Pastore, Giulia Elena Mandoli, Alberto Giannoni, et al.
JACC. Advances|June 28, 2024
Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based AnalysisAlessandro Pierri, Stefano Albani, Marco Merlo, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
International Journal of Cardiology|November 7, 2025
Impact of cardiac magnetic resonance on the clinical management of patients with Fabry disease: Data from the CMR Italian research and CLinical nEtwork for Fabry disease (CIRCLE-FD)Antonia Camporeale, Giada De Angeli, Gianluigi Guida, et al.
Circulation. Heart Failure|February 24, 2026
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac AmyloidosisMattia Zampieri, Giulia Biagioni, Annamaria Del Franco, et al.
ESC Heart Failure|May 14, 2021
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide surveyGiacomo Tini, Francesco Cappelli, Elena Biagini, et al.
ESC Heart Failure|November 30, 2022
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic RegistryGiulia Elena Mandoli, Maria Concetta Pastore, Alberto Giannoni, et al.
Circulation|February 8, 2024
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Marianna Fontana, Marco Canepa, et al.
Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)]Aldostefano Porcari, Cristina Chimenti, Marco Merlo, et al.
Journal of the American College of Cardiology|June 12, 2024
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Francesco Cappelli, Christian Nitsche, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Tissue characterization in cardiac amyloidosis: a joint consensus document by the gruppo di studio di cardiopatologia (SIAPEC) and the SIC/ANMCO Italian cardiac amyloidosis network (RIAC)Giuseppe Vergaro, Carla Giordano, Angela Pucci, et al.
European Heart Journal Open|August 3, 2022
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian registerMaria Concetta Pastore, Giulia Elena Mandoli, Alberto Giannoni, et al.
JACC. Advances|June 28, 2024
Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based AnalysisAlessandro Pierri, Stefano Albani, Marco Merlo, et al.
Pageof 17